Brief: Surface Oncology Announces FDA Clearance Of IND Application For Gsk4381562, A Novel Antibody Targeting Pvrig
01/12/2021 12:34
Dec 1 (Reuters) - Surface Oncology Inc SURF.O :
* SURFACE ONCOLOGY ANNOUNCES FDA CLEARANCE OF IND
APPLICATION FOR
GSK4381562, A NOVEL ANTIBODY TARGETING PVRIG
Source text for Eikon: ID:nGNX7QPLJW
Further company coverage: SURF.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Surface Oncology
See all newsBrief: Surface Oncology Says Anticipates Will Have Net Cash Of $20 Million To $25 Million At The Closing Of The Proposed Mergers
Surface Oncology Inc reports results for the quarter ended in June - Earnings Summary
Brief: Surface Oncology, Inc. Q2 Net Income USD -28.2 Mln
Surface Oncology Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: ADAR1 Partners Reports 5.24% Passive Stake In Surface Oncology Inc As Of July 10 - SEC Filing